data management
data available
data ingestion
data acquisition
trial data
Data Integration
monitoring of patients
Consortium Management
data quality assurance features
generalizable aggregation capability of participant data
Relapse
end-to-end platform
long term outcomes of patients
end-to-end technological platform
Remote Assessment of Disease
effective communication infrastructure
disease state
disease course
patient outcomes
efficient exploitation of project results
dissemination cluster
multiple classes of devices
Excellent project oversight
remote monitoring technology
user devices
good practice of resource management
multiple sclerosis
multiple parameters
active monitoring
modelling infrastructure applicable
fine-grained information
Technological platforms cluster
exploitation strategy
technological innovation
Smartphone
analysis methodology
application of RMT
consortium members
future-proofed
field
pipeline
Long term conditions
predictive power of RMT
private-public partnership
new sensors
patient feedback
scientific community
clinic visits
efficient care
wearable technologies
implementation barriers
scientific awareness of RADAR
advanced real-time analytics capability
Central Nervous System Disorders Background
reports
scientists
maximum benefit
technical expertise
risk of significant changes
treatment effects
experience sampling
protection of intellectual property
successful transmission of sensor
place unnecessary burden
industry
IMI2
adverse events
adaptability
CNS
tools
Governance
real time
Biosignatures
facilitators
scale
ideal way
characterised clinical cohorts of diseases
pathways
study
capture
individuals
inherent challenges
services
enhanced modularity
main components
payers
clinicians
providers
feasibility
networking
depression
applications
European society
performance improvements
exponential growth
regulatory approval
uptake
epilepsy
contractual duties
flexibility of design
health
ultimate goal
server
WP8
WP11
workpackages
processes
Program of Work
areas
low cost
WP7
clusters
infancy
impacts